“Biogen has been, and continues to be, committed to working with all stakeholders to ensure SPINRAZA is available as an option for people with SMA to treat this devastating disease,” said David Henderson, the managing director of Biogen Australia and New Zealand. …
Expanded funding of SPINRAZA for treatment of pre-symptomatic SMA babies
March 4, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
TGA approves new indication for GSK's RSV vaccine
April 24, 2025 - - Latest News -
It's important to understand that health technology assessment is not an enabler
April 24, 2025 - - Latest News -
The Dispatched Podcast 'Week/s in Review' - 24 April
April 23, 2025 - - Podcast -
Roche announces historic investment to build US manufacturing base
April 23, 2025 - - Latest News -
US trade agenda looks mostly disinterested in pharmaceuticals
April 23, 2025 - - Latest News -
'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'
April 23, 2025 - - Latest News -
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 - - Australian Biotech